1 result

• J&J Settles Risperdal Lawsuit Over Illegal Marketing for $2.2B

  November 5, 2013

  Irvin Jackson

  Johnson & Johnson is paying more than $2 billion in fines and liability for illegally promoting Risperdal as a chemical restraint for elderly nursing home patients and paying doctors to promote the drug even when they knew it was dangerous.